Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Abstracts Reporting EarlyCDTâ„¢-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers

May 12, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

DENVER, May 12, 2011 /- Oncimmune ® LLC , maker of EarlyCDT™-Lung , a simple blood test that aids physicians in the risk assessment and early detection of lung cancer , today announced that four poster presentations during the American Thoracic Society's (ATS) International...

How are you influencing patient management devices?

May 11, 2011 10:17 am | Articles | Comments

Rudye McGlothlin, Product Marketing Engineer at Texas Instruments, Chris Mertens, Vice President of Healthcare at HP PSG, and Alex Brisbourne, President and COO at KORE Telematics, respond to the question, “How are you influencing patient management devices?”

Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate

May 11, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, May 11, 2011 /- Instacare Corp. (OTCQB: ISCR), the exclusive provider of the Shasta Genstrip, a revolutionary diagnostic product targeted at the $20 billion diabetes care marketplace, a leading provider of prescription diagnostics and home testing products for the chronically...

Advertisement

Vemurafenib New Drug Application Submitted to FDA for Melanoma

May 11, 2011 2:31 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and TOKYO, May 11, 2011 /- Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA)....

American Imaging Management Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection

May 10, 2011 10:32 am | by Bio-Medicine.Org | News | Comments

CHICAGO, May 10, 2011 /- American Imaging Management (AIM) was selected as one of 20 finalists for the 2011 URAC Awards for Best Practices in Health Care Consumer Empowerment and Protection. URAC, the nation's leading accreditation organization, will honor the finalists during URAC's 12th...

Vermillion Reports Financial Results for the First Quarter 2011

May 10, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, May 10, 2011 /- Vermillion, Inc . (Nasdaq: VRML ), a molecular diagnostics company, today reported financial results for the first quarter ended March 31, 2011.  Key milestones we have achieved since the last quarterly conference call include: Performed an...

Concord Medical Services Holdings to Present at Two Upcoming Conferences

May 10, 2011 3:31 am | by Bio-Medicine.Org | News | Comments

BEIJING, May 10, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it is scheduled to present at...

Radiologists Need to Contribute to Research

May 9, 2011 1:33 pm | by Diagnostic Imaging | News | Comments

Only a few radiologists understand how to make a policy case for the value of diagnostic procedures. More need to contribute to research and prove that continued coverage is worthwhile.

Advertisement

Knowing When Work Has Taken Over Your Life

May 9, 2011 1:33 pm | by Diagnostic Imaging | News | Comments

I recently heard some news about a colleague from my residency. He's doing quite well for himself, holding a full-time job and also covering extra hours on the side. I know more than a few full-time radiologists whose annual salaries are less than half of what he's earning, so it was a...

Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China

May 9, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., QUEENSLAND, Australia and BEIJING, May 9, 2011 /- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the formation of...

Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement

May 9, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., May 9, 2011 /- Quest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX ), today announced its national sponsorship of Choose You®, the American Cancer Society's movement that inspires women to stay well by putting...

TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members

May 9, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., May 9, 2011 /- TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the appointment of Mr. Supratim Bose and Mr. Michael Kleine to their Board of Directors. Mr. Bose,...

Samsung Medison Pledges to Become a World-Class Medical Device Company

May 9, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

CYPRESS, Calif., May 9, 2011 /- Medison and Samsung Electronics jointly announced a new corporate identity of Samsung Medison. The combined company, a joint partnership between Korea's leading diagnostic ultrasound equipment manufacturer and one of the world's largest and most...

Advertisement

Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments

May 9, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments...

Sexual orientation affects cancer survivorship

May 8, 2011 8:41 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors. Those are the conclusions of a new study published early online in Cancer,...

Prevalence of autism in South Korea estimated at 1 in 38 children

May 8, 2011 8:39 pm | by EurekAlert | News | Comments

(Yale University) Autism spectrum disorders (ASD) in South Korea affect an estimated 2.64 percent of the population of school-age children, equivalent to 1 in 38 children, according to the first comprehensive study of autism prevalence using a total population sample. The study --...

Season of birth and celiac disease in Massachusetts children

May 8, 2011 5:45 am | by EurekAlert | News | Comments

(Digestive Disease Week) Celiac disease is more common among Massachusetts children born in the spring or summer, and this higher incidence could be related to the intersection of key seasonal and environmental factors, according to researchers at the Massachusetts General Hospital for Children.

Socioeconomic status influences celiac disease diagnosis

May 8, 2011 5:44 am | by EurekAlert | News | Comments

(Digestive Disease Week) Income is a pivotal factor in whether a patient without common symptoms of celiac disease is accurately diagnosed with the digestive condition, according to a new study from the Beth Israel Deaconess Medical Center in Boston, Mass.

Cardiac Network Announces Reverse Stock Split

May 6, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, May 5, 2011 /- Cardiac Network, Inc. (Other OTC: CNWI.PK) (the "Company") today announced that the Company will effect a 1-for-750 reverse stock split (the "Reverse Stock Split"). The Reverse Stock Split will take effect on the opening of business and trading on May 6, 2011...

BD Launches BD MAXâ„¢ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians

May 6, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

MILAN, May 6, 2011 /- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced...

Providing More Detailed Diagnosis in Less Time

May 5, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, May 5, 2011 /PRNewswire-Asia/ -- People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy...

Do You Get Politically Involved?

May 5, 2011 8:31 am | by Diagnostic Imaging | News | Comments

Take our poll or comment on the governement and radiology.

Malpractice Cases Fewer, Communication Still Key

May 5, 2011 8:31 am | by Diagnostic Imaging | News | Comments

Although 40 percent of surveyed mammographers anticipate a suit in the next five years, in reality 10 percent will face a legal challenge.

Quest Diagnostics Launches Simplexaâ„¢ C. Difficile Universal Direct Test in Europe

May 5, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J. and CYPRESS, Calif., May 5, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile Universal Direct test on the 3M™...

Concord Medical to Report First Quarter 2011 Financial Results on Wednesday, May 18, 2011

May 5, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

BEIJING, May 5, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading